Traders sold shares of UnitedHealth Group Inc. (NYSE:UNH) on strength during trading on Wednesday. $46.80 million flowed into the stock on the tick-up and $72.01 million flowed out of the stock on the tick-down, for a money net flow of $25.21 million out of the stock. Of all companies tracked, UnitedHealth Group had the 16th highest net out-flow for the day. UnitedHealth Group traded up $0.37 for the day and closed at $142.19

Several analysts have issued reports on the company. Barclays PLC boosted their target price on UnitedHealth Group from $151.00 to $164.00 and gave the company an “overweight” rating in a research note on Wednesday, July 20th. Credit Suisse Group AG reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Leerink Swann reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Royal Bank Of Canada boosted their price objective on UnitedHealth Group from $157.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday, July 20th. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective on the stock in a research note on Friday, July 22nd. One analyst has rated the stock with a hold rating, twenty-four have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $153.44.

The stock has a market capitalization of $135.42 billion and a PE ratio of 22.25. The stock has a 50-day moving average of $141.37 and a 200 day moving average of $130.56.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. The firm earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. On average, equities research analysts expect that UnitedHealth Group Inc. will post $7.91 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th will be issued a $0.625 dividend. The ex-dividend date of this dividend is Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.76%.

In related news, Director Gail R. Wilensky sold 5,500 shares of UnitedHealth Group stock in a transaction dated Friday, June 10th. The stock was sold at an average price of $139.80, for a total value of $768,900.00. Following the completion of the transaction, the director now owns 59,019 shares in the company, valued at $8,250,856.20. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction dated Thursday, June 16th. The stock was sold at an average price of $138.58, for a total value of $692,900.00. Following the completion of the transaction, the director now owns 72,229 shares of the company’s stock, valued at approximately $10,009,494.82. The disclosure for this sale can be found here.

Other hedge funds and institutional investors recently added to or reduced their stakes in the company. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its position in UnitedHealth Group by 2.6% in the fourth quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 10,013 shares of the healthcare conglomerate’s stock valued at $1,178,000 after buying an additional 255 shares in the last quarter. Argent Trust Co raised its position in UnitedHealth Group by 0.5% in the third quarter. Argent Trust Co now owns 13,437 shares of the healthcare conglomerate’s stock valued at $1,559,000 after buying an additional 65 shares in the last quarter. Girard Partners LTD. raised its position in UnitedHealth Group by 17.9% in the fourth quarter. Girard Partners LTD. now owns 18,358 shares of the healthcare conglomerate’s stock valued at $2,160,000 after buying an additional 2,792 shares in the last quarter. Victory Capital Management Inc. raised its position in UnitedHealth Group by 224.8% in the fourth quarter. Victory Capital Management Inc. now owns 18,755 shares of the healthcare conglomerate’s stock valued at $2,206,000 after buying an additional 12,981 shares in the last quarter. Finally, Airain ltd bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $2,209,000.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.